Evergen Biotechnologies Overview

  • Founded
  • 2000
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Investors
  • 3

Evergen Biotechnologies General Information


Developer of an industrial-scaled technology designed to produce sexed bovine embryos by in vitro fertilization. The company's technology engages in the research, development, production and distribution of biological products and services related to embryo biotechnologies, including nuclear transfer technology for animal cloning, in vitro and in vivo embryo production and transgenic animal production, enabling dairy farms to improve cattle genetics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • 428 Hartford Turnpike
  • Suite 107
  • Vernon, CT 06066
  • United States
+1 (860) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Evergen Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 09-Jan-2008 Completed Generating Revenue
2. Grant 01-Jan-2008 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) Completed Startup
To view Evergen Biotechnologies’s complete valuation and funding history, request access »

Evergen Biotechnologies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
United States Department of Agriculture Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
DowsLake Venture Venture Capital Minority 000 0000 000000 0
To view Evergen Biotechnologies’s complete investors history, request access »